|
|
|
|
||
2009 newsPrecigen Receives Fda Clearance Of Ind To Initiate Phase 2 Study Of Prgn-2009 Off-the-shelf Adenoverse Immunotherapy In Combination With Pembrolizumab.. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
53971 | Re: 2009 news | Mabel | 2 | 5/31/2023 10:06:49 AM |